Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia
- 1 April 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (4), 901-904
- https://doi.org/10.1128/aac.38.4.901
Abstract
The aim of the study was to evaluate the penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia. For this purpose, in each patient studied, simultaneous serial blood and bronchial secretion samples were obtained over a 12-h period on days 2 and 4. Eight patients were included in the study. Ciprofloxacin was given at a dose of 200 mg over 30 min by using an automatic pump. Ciprofloxacin was measured by high-performance liquid chromatography. Peak levels of drug in serum were 2.95 +/- 1 mg/liter on day 2 and 2.43 +/- 0.7 mg/liter on day 4. Peak and trough levels in bronchial secretions were 0.95 +/- 0.51 and 0.21 +/- 0.12 mg/liter, respectively, on day 2 and 0.76 +/- 0.17 and 0.18 +/- 0.14 mg/liter, respectively, on day 4. The ratios of peak concentrations in bronchial secretions/serum were 0.32 +/- 0.11 and 0.33 +/- 0.06 on days 2 and 4, respectively. The ratios of the area under the concentration-time curve from 0 to 12 h (AUC0-12) for bronchial secretions/those for serum were 0.66 +/- 0.40 and 0.55 +/- 0.30 on days 2 and 4, respectively. A significant positive correlation was found on day 4 between the AUC0-12 for serum and the AUC0-12 for bronchial secretions. No significant correlations were found between peak values in serum and bronchial secretions.Keywords
This publication has 18 references indexed in Scilit:
- The importance of tissue antibiotic activity in the prevention of operative wound infectionJournal of Antimicrobial Chemotherapy, 1989
- Penetration of ciprofloxacin in bronchial secretions after intravenous administrationJournal of Antimicrobial Chemotherapy, 1988
- Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patientsJournal of Antimicrobial Chemotherapy, 1987
- CIPROFLOXACIN PENETRATION INTO LUNGSThe Lancet, 1987
- Ciprofloxacin in acute exacerbations of chronic bronchitisJournal of Antimicrobial Chemotherapy, 1986
- Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patientsAntimicrobial Agents and Chemotherapy, 1986
- Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Penetration of ciprofloxacin into bronchial secretionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1984
- In-vitro studies with ciprofloxacin, a new 4-quinolone compoundJournal of Antimicrobial Chemotherapy, 1984